---
title: Tubulis
date: 2020-07-21T09:16:13Z
modified: 2026-08-12T09:08:34Z
permalink: "https://www.htgf.de/en/portfolio/htgffamily/tubulis/"
type: portfolio
status: publish
excerpt: ""
wpid: 80858
language:
  - English
post_translations:
  - pll_5f118e2f2e9c5
branchen22:
  - Oncology
sectors:
  - Pharmaceuticals
focus_areas:
  - Oncology
timestamp: 2026-08-12T09:08:34Z
tags:
  - English
  - pll_5f118e2f2e9c5
  - Oncology
  - Pharmaceuticals
---

## Beschreibungstext

Development of enhanced antibody-drug conjugates for improved cancer treatment

## Lange Beschreibung

Tubulis generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Our goal is to expand the therapeutic potential of antibody drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients. Employing the company’s proprietary ADC development approach, Tubulis will advance a variety of conjugates, unlimited by indication.

## Unternehmenswebsite

www.tubulis.com

## Adresse

Tubulis GmbH
Butenandtstraße 1
81377 Munich
Germany

## Kontakt

Array